GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (TSX:TLRY) » Definitions » EV-to-EBITDA
中文

Tilray Brands (TSX:TLRY) EV-to-EBITDA

: -13.25 (As of Today)
View and export this data going back to 2011. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Tilray Brands's enterprise value is C$2,302 Mil. Tilray Brands's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was C$-174 Mil. Therefore, Tilray Brands's EV-to-EBITDA for today is -13.25.

The historical rank and industry rank for Tilray Brands's EV-to-EBITDA or its related term are showing as below:

TSX:TLRY' s EV-to-EBITDA Range Over the Past 10 Years
Min: -174.44   Med: -7.3   Max: 42529.82
Current: -13.03

During the past 12 years, the highest EV-to-EBITDA of Tilray Brands was 42529.82. The lowest was -174.44. And the median was -7.30.

TSX:TLRY's EV-to-EBITDA is ranked worse than
100% of 708 companies
in the Drug Manufacturers industry
Industry Median: 13.88 vs TSX:TLRY: -13.03

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-24), Tilray Brands's stock price is C$2.52. Tilray Brands's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.596. Therefore, Tilray Brands's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Tilray Brands EV-to-EBITDA Historical Data

The historical data trend for Tilray Brands's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -107.26 -24.66 -32.08 -10.72 -0.98

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.19 -0.98 -1.79 -1.31 -12.29

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands EV-to-EBITDA Distribution

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tilray Brands's EV-to-EBITDA falls into.



Tilray Brands EV-to-EBITDA Calculation

Tilray Brands's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2301.774/-173.725
=-13.25

Tilray Brands's current Enterprise Value is C$2,302 Mil.
Tilray Brands's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-174 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tilray Brands  (TSX:TLRY) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Tilray Brands's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.52/-0.596
=At Loss

Tilray Brands's share price for today is C$2.52.
Tilray Brands's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.596.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Tilray Brands EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tilray Brands's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (TSX:TLRY) Business Description

Traded in Other Exchanges
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.